brand logo

Am Fam Physician. 1999;59(11):2983a-2984

to the editor: I enjoyed the excellent article, “Management of Female Sexual Assault,” by Drs. Petter and Whitehill.1 I have a comment related to the discussion of prophylactic treatment of sexually transmitted diseases (STDs) in victims of sexual assault. The authors state that treatment “. . . should include prophylaxis for gonorrhea, Chlamydia, and syphilis . . . ,” but that “. . . trichomoniasis should be treated only if seen on the wet mount examination.” The Centers for Disease Control and Prevention (CDC) disagrees.

The CDC's document “1998 Guidelines for Treatment of Sexually Transmitted Diseases”2 regarding sexual assault and STDs recommends empiric postexposure prophylaxis, not only for Chlamydia, gonorrhea and hepatitis (if the patient is not immunized), but also for Trichomonas and bacterial vaginosis, by adding one 2-g oral dose of metronidazole to the usual prophylactic therapy for STDs.

editor's note: This letter was sent to the authors of “Management of Female Sexual Assault,” who declined to reply.

Email letter submissions to Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Continue Reading

More in AFP

Copyright © 1999 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.